Apyx Medical Corp. (NASDAQ: APYX) reported Q2 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $13.9 million versus the consensus estimate of $13.32 million.

GUIDANCE:

Apyx Medical Corp. sees FY2026 revenue of $59-60 million, versus the consensus of $59.55 million.

For earnings history and earnings-related data on Apyx Medical Corp. (APYX) click here.